Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

3.

Protein expression differences between lung adenocarcinoma and squamous cell carcinoma with brain metastasis.

Fábián K, Németh Z, Furák J, Tiszlavicz L, Pápay J, Krenács T, Tímár J, Moldvay J.

Anticancer Res. 2014 Oct;34(10):5593-7.

PMID:
25275061
4.

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer.

Podmaniczky E, Fábián K, Pápay J, Puskás R, Gyulai M, Furák J, Tiszlavicz L, Losonczy G, Tímár J, Moldvay J.

Pathol Oncol Res. 2015 Apr;21(2):423-31. doi: 10.1007/s12253-014-9839-x. Epub 2014 Sep 7.

PMID:
25194563
5.

[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission].

Moldvay J, Pápay J, Kovalszky I, Balázs G, Puskás R, Losonczy G.

Magy Onkol. 2014 Jun;58(2):133-7. Epub 2014 Mar 5. Hungarian.

6.

An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.

Cheetham TC, Lee J, Hunt CM, Niu F, Reisinger S, Murray R, Powell G, Papay J.

Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):601-8. doi: 10.1002/pds.3531. Epub 2013 Oct 21.

PMID:
24920207
7.

Ready to Lead, But How? Teachers' Experiences in High-poverty Urban Schools.

Johnson SM, Reinhorn SK, Charner-Laird M, Kraft MA, Ng M, Papay JP.

Teach Coll Rec (1970). 2014;116(10). pii: 17601. No abstract available.

8.

Fixation stability and scotoma mapping for patients with low vision.

Elsner AE, Petrig BL, Papay JA, Kollbaum EJ, Clark CA, Muller MS.

Optom Vis Sci. 2013 Feb;90(2):164-73. doi: 10.1097/OPX.0b013e31827cda72.

9.

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data.

Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC.

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):190-8. doi: 10.1002/pds.3388. Epub 2012 Dec 19.

PMID:
23258383
10.

A pre-marketing ALT signal predicts post-marketing liver safety.

Moylan CA, Suzuki A, Papay JI, Yuen NA, Ames M, Hunt CM.

Regul Toxicol Pharmacol. 2012 Aug;63(3):433-9. doi: 10.1016/j.yrtph.2012.05.016. Epub 2012 Jun 2.

PMID:
22668747
11.

Cone photoreceptor packing density and the outer nuclear layer thickness in healthy subjects.

Chui TY, Song H, Clark CA, Papay JA, Burns SA, Elsner AE.

Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3545-53. doi: 10.1167/iovs.11-8694.

12.

Validation of diagnostic accuracy using digital slides in routine histopathology.

Fónyad L, Krenács T, Nagy P, Zalatnai A, Csomor J, Sápi Z, Pápay J, Schönléber J, Diczházi C, Molnár B.

Diagn Pathol. 2012 Mar 31;7:35. doi: 10.1186/1746-1596-7-35.

13.

Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.

Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T.

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):289-96. doi: 10.1002/pds.2276. Epub 2011 Dec 5.

PMID:
22139991
14.

[Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy].

Moldvay J, Pápay J, Puskás R, Furák J, Losonczy G, Matolcsy A.

Magy Onkol. 2011 Jun;55(2):105-9. doi: MagyOnkol.2011.55.2.105. Epub 2011 Feb 7. Hungarian.

15.

Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.

Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G.

Int Immunol. 2011 Jun;23(6):405-14. doi: 10.1093/intimm/dxr026. Epub 2011 May 19.

16.

The evaluation of drug rechallenge: the casopitant Phase III program.

Hunt CM, Papay JI, Rich DS, Abissi CJ, Russo MW.

Regul Toxicol Pharmacol. 2010 Dec;58(3):539-43. doi: 10.1016/j.yrtph.2010.09.014. Epub 2010 Oct 13.

PMID:
20932869
17.

Response to Letter to the editor by Papay: Regulatory Toxicology and Pharmacology 54 (2009), pp. 84-90. Drug-induced liver injury following positive drug rechallenge.

Papay J.

Regul Toxicol Pharmacol. 2009 Aug;54(3):314. doi: 10.1016/j.yrtph.2009.05.007. Epub 2009 May 19. No abstract available.

PMID:
19460410
18.

Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury.

Suzuki A, Yuen N, Walsh J, Papay J, Hunt CM, Diehl AM.

Clin Gastroenterol Hepatol. 2009 Aug;7(8):882-8. doi: 10.1016/j.cgh.2009.03.034. Epub 2009 Apr 9.

PMID:
19362607
19.

Drug-induced liver injury following positive drug rechallenge.

Papay JI, Clines D, Rafi R, Yuen N, Britt SD, Walsh JS, Hunt CM.

Regul Toxicol Pharmacol. 2009 Jun;54(1):84-90. doi: 10.1016/j.yrtph.2009.03.003. Epub 2009 Mar 18.

PMID:
19303041
20.

Platinum-based chemotherapy in lung cancer affects the expression of certain biomarkers including ERCC1.

Pápay J, Sápi Z, Egri G, Gyulai M, Szende B, Losonczy G, Tímár J, Moldvay J.

Pathol Oncol Res. 2009 Sep;15(3):445-50. doi: 10.1007/s12253-009-9155-z. Epub .

PMID:
19253035
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk